Scientists uncover a novel mechanism controlling tumor growth in the brain

June 8, 2009,

As survival rates among some patients with cancer continue to rise, so does the spread of these cancers to the brain - as much as 40 percent of all diagnosed brain cancers are considered metastatic, having spread from a primary cancer elsewhere in the body.

Now, scientists from The Scripps Research Institute have discovered a molecular mechanism that plays a pivotal role in controlling in the brain. The discovery could provide a basis for potentially effective therapies for the treatment of .

The study was published in an online Early Edition of the journal Proceedings of the National Academy of Sciences (PNAS) the week of June 8, 2009.

"Our study could have a broad impact because it explains at a molecular level how metastatic lesions thrive in the brain," said Scripps Research Associate Professor Brunhilde Felding-Habermann, who led the research. "This offers a potential target for inhibiting the growing problem of brain metastasis."

For that have invaded the brain, Felding-Habermann and her colleagues found that when activated, a tumor known as integrin αvβ3 increased the supply of a growth factor involved in the development of new ("angiogenesis") necessary for tumor expansion within the brain tissue. In contrast, the same receptor did not influence tumor growth at the primary cancer site, in this case, the breast.

"The fact that we uncovered a link between activated αvβ3 and angiogenesis is quite striking," said Senior Research Associate Mihaela Lorger, the first author of the study. "In addition, our study showed that that the ability of tumor cell αvβ3 to enhance angiogenesis depends very much on the microenvironment."

This receptor's varying effects on tumor cells depending on their location in the body reinforces a principle that the Felding-Habermann lab uncovered a few years ago.

"For tumor cells, it's not just the presence of the receptor on the cells, but the conformation or shape of the molecule that determines how well tumor cells can do within different tissues" Felding-Habermann said. "The shape of the molecule can increase or reduce the receptor's affinity for its natural ligands."

In the new study, which was conducted in mouse models, the scientists showed that activated αvβ3 on tumor cells leads to angiogenesis in the brain by elevating the expression of the VEGF, a protein that is critical to the formation of new blood vessels.

Tumor cells normally try to recruit more blood vessels when oxygen supply runs low. When oxygen and nutrients get scarce, many tumor cells die and tumor growth slows down until new vessels have formed. But in the brain, activated αvβ3 promotes rapid tumor growth by enabling tumor cells to attract new blood vessels continuously, even when oxygen is still abundant.

The scientists plan to follow up on their new findings by testing if activated αvβ3 on tumor cells also supports brain metastasis of other types of cancer, and by investigating if targeting the activated form of αvβ3 can inhibit metastatic brain disease.

Source: The Scripps Research Institute (news : web)

Related Stories

Recommended for you

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.